Absci Corp (ABSI)

$3.55 -0.18 (-4.83%)
Market Cap 455.63M
Revenue (ttm) 4.53M
Net Income (ttm) -103.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,276.16%
Debt to Equity Ratio 0.01
Volume 2,370,100
Avg Vol 5,486,612
Day's Range N/A - N/A
Shares Out 150.37M
Stochastic %K 98%
Beta 2.13
Analysts Strong Sell
Price Target $8.11

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
ZacksResearch
ZacksResearch Dec. 5 at 4:05 PM
$ABSI jumps 13.4% after dosing begins in alopecia study The phase I/IIa HEADLINE study for ABS-201, an anti-PRLR antibody, is evaluating safety and tolerability as primary endpoints, with secondary endpoints including PK, PD, and early efficacy indicators. Interim data is expected in the second half of 2026. Discover the full potential of this novel treatment here 👉 https://www.zacks.com/stock/news/2800375/absi-stock-up-on-initiating-dosing-in-androgenetic-alopecia-study?cid=sm-stocktwits-2-2800375-body-23638&ADID=SYND_STOCKTWITS_TWEET_2_2800375_BODY_23638
0 · Reply
BioSniper101
BioSniper101 Dec. 5 at 4:03 PM
$RXRX $ABSI. To me, the trading behavior looks identical to what PLTR went through. I know from first hand experience. GLTAL
1 · Reply
cryptodhir
cryptodhir Dec. 5 at 3:41 PM
$ABSI good news brings me down
1 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 3:05 PM
$ABSI pops on a fresh catalyst — early-stage biotech momentum can move fast. The stock jumped after the company began dosing in its phase I/IIa ABS-201 study for androgenetic alopecia, aiming to gather those first safety and efficacy signals that can set the tone for what’s next. Full details here 👉 https://www.zacks.com/stock/news/2800375/absi-stock-up-on-initiating-dosing-in-androgenetic-alopecia-study?cid=sm-stocktwits-2-2800375-teaser-23623&ADID=SYND_STOCKTWITS_TWEET_2_2800375_TEASER_23623
0 · Reply
SonicPriced
SonicPriced Dec. 5 at 12:45 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $SMX $ABSI $ABAT $SLMT Green!
0 · Reply
BearTamerTrading
BearTamerTrading Dec. 5 at 1:20 AM
🔥 Recap — Alerted Across All Three Streams Part 2 of 2 🔥 $WAI — Low-float mover with volatility spikes 🔥 $NFE — Strong intraday momentum + energy sector strength 🔥 $QCLS — Tech/AI interest + steady volume build 🔥 $ABSI — Biotech rotation + liquidity push 🔥 $KALA — Pharma momentum + early premarket demand All alerted live during today’s three sessions — multiple clean profit windows from start to finish. 🎥 Full Replay: https://www.youtube.com/live/pfrydfqocIE?si=-vm7HB_Uw_qhEXnQ
0 · Reply
LabPsycho
LabPsycho Dec. 4 at 6:21 PM
$ABSI @musky54 yes, the news was a surprise. Frankly I would prefer companies never allude to a potential partnership...tends to be a let down in my observation. About the hair - It does make me wonder—is the market for hair-loss drugs really as secure as everyone thinks? Crazy thought but I am thinking with the trajectory of medical science and cosmetic surgery, we’re heading toward a world where hair restoration is basically an oil change for your scalp. IMO, we’ll likely have either lab-grown follicular simulacrums (yes, I’m keeping that masterpiece) or CRISPR-enhanced follicle farms, pseudo-allogenic donor strands ethically sourced from “hirsutely gifted volunteers,” (lol - I cracked myself up with that one) and hey, why not possibly a subscription service where your hair gets auto-updated like Windows. You’ll walk into a clinic bald and walk out one hour later looking like someone pressed the ‘Chia Pet: Ultra-Luxe Edition’ button on your head.
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 4 at 5:42 PM
Dufus here, $ABSI has turned -3% lower to 14% (~7Mv) a few minutes ago, 12/19 options, follow for more volatility.
0 · Reply
LabPsycho
LabPsycho Dec. 4 at 5:32 PM
$ABSI @musky54 Well, there's your news you've been wanting...
1 · Reply
Mycycle
Mycycle Dec. 4 at 5:08 PM
$ABSI Been holing 7,000 shares at 3.07 a share holding on for the ride!
0 · Reply
Latest News on ABSI
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Dec 4, 2025, 8:00 AM EST - 1 day ago

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

10 AI Stocks Worth Buying Right Now

Dec 4, 2025, 5:45 AM EST - 1 day ago

10 AI Stocks Worth Buying Right Now

AI BBAI CLBT PATH PLTR RXRX SOUN

Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 21, 2025, 7:23 PM EST - 13 days ago

Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 Transcript

Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 10:31 PM EST - 22 days ago

Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 12, 2025, 4:05 PM EST - 22 days ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 29, 2025, 4:05 PM EDT - 5 weeks ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Participate in Upcoming Investor Conferences

Oct 27, 2025, 8:00 AM EDT - 5 weeks ago

Absci to Participate in Upcoming Investor Conferences

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Oct 15, 2025, 8:00 AM EDT - 7 weeks ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

Sep 11, 2025, 12:10 PM EDT - 3 months ago

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:13 AM EDT - 3 months ago

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 3 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 12:25 AM EDT - 4 months ago

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 4 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 4 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 4 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jul 25, 2025, 8:34 AM EDT - 4 months ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 4 months ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 4 months ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 5 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:45 PM EDT - 7 months ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 7 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 7 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 8 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Apr 3, 2025, 3:15 PM EDT - 8 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 9 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 9 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 9 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 9 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 4:00 PM EST - 9 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 9 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 10 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Jan 22, 2025, 1:22 PM EST - 11 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 11 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Jan 13, 2025, 2:05 AM EST - 11 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 11 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 11 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 11 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:01 AM EST - 1 year ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Oct 3, 2024, 12:36 PM EDT - 1 year ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 11:50 PM EDT - 1 year ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 28, 2024, 1:24 AM EDT - 1 year ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

ZacksResearch
ZacksResearch Dec. 5 at 4:05 PM
$ABSI jumps 13.4% after dosing begins in alopecia study The phase I/IIa HEADLINE study for ABS-201, an anti-PRLR antibody, is evaluating safety and tolerability as primary endpoints, with secondary endpoints including PK, PD, and early efficacy indicators. Interim data is expected in the second half of 2026. Discover the full potential of this novel treatment here 👉 https://www.zacks.com/stock/news/2800375/absi-stock-up-on-initiating-dosing-in-androgenetic-alopecia-study?cid=sm-stocktwits-2-2800375-body-23638&ADID=SYND_STOCKTWITS_TWEET_2_2800375_BODY_23638
0 · Reply
BioSniper101
BioSniper101 Dec. 5 at 4:03 PM
$RXRX $ABSI. To me, the trading behavior looks identical to what PLTR went through. I know from first hand experience. GLTAL
1 · Reply
cryptodhir
cryptodhir Dec. 5 at 3:41 PM
$ABSI good news brings me down
1 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 3:05 PM
$ABSI pops on a fresh catalyst — early-stage biotech momentum can move fast. The stock jumped after the company began dosing in its phase I/IIa ABS-201 study for androgenetic alopecia, aiming to gather those first safety and efficacy signals that can set the tone for what’s next. Full details here 👉 https://www.zacks.com/stock/news/2800375/absi-stock-up-on-initiating-dosing-in-androgenetic-alopecia-study?cid=sm-stocktwits-2-2800375-teaser-23623&ADID=SYND_STOCKTWITS_TWEET_2_2800375_TEASER_23623
0 · Reply
SonicPriced
SonicPriced Dec. 5 at 12:45 PM
Gotta give it to @Invinc1ble dude’s been on a hot streak 🔥 Worth a follow! $SMX $ABSI $ABAT $SLMT Green!
0 · Reply
BearTamerTrading
BearTamerTrading Dec. 5 at 1:20 AM
🔥 Recap — Alerted Across All Three Streams Part 2 of 2 🔥 $WAI — Low-float mover with volatility spikes 🔥 $NFE — Strong intraday momentum + energy sector strength 🔥 $QCLS — Tech/AI interest + steady volume build 🔥 $ABSI — Biotech rotation + liquidity push 🔥 $KALA — Pharma momentum + early premarket demand All alerted live during today’s three sessions — multiple clean profit windows from start to finish. 🎥 Full Replay: https://www.youtube.com/live/pfrydfqocIE?si=-vm7HB_Uw_qhEXnQ
0 · Reply
LabPsycho
LabPsycho Dec. 4 at 6:21 PM
$ABSI @musky54 yes, the news was a surprise. Frankly I would prefer companies never allude to a potential partnership...tends to be a let down in my observation. About the hair - It does make me wonder—is the market for hair-loss drugs really as secure as everyone thinks? Crazy thought but I am thinking with the trajectory of medical science and cosmetic surgery, we’re heading toward a world where hair restoration is basically an oil change for your scalp. IMO, we’ll likely have either lab-grown follicular simulacrums (yes, I’m keeping that masterpiece) or CRISPR-enhanced follicle farms, pseudo-allogenic donor strands ethically sourced from “hirsutely gifted volunteers,” (lol - I cracked myself up with that one) and hey, why not possibly a subscription service where your hair gets auto-updated like Windows. You’ll walk into a clinic bald and walk out one hour later looking like someone pressed the ‘Chia Pet: Ultra-Luxe Edition’ button on your head.
0 · Reply
_www_larval_com_
_www_larval_com_ Dec. 4 at 5:42 PM
Dufus here, $ABSI has turned -3% lower to 14% (~7Mv) a few minutes ago, 12/19 options, follow for more volatility.
0 · Reply
LabPsycho
LabPsycho Dec. 4 at 5:32 PM
$ABSI @musky54 Well, there's your news you've been wanting...
1 · Reply
Mycycle
Mycycle Dec. 4 at 5:08 PM
$ABSI Been holing 7,000 shares at 3.07 a share holding on for the ride!
0 · Reply
BioSniper101
BioSniper101 Dec. 4 at 5:02 PM
$ABSI Now we’re talking. Rise and Shine
0 · Reply
Kennynails
Kennynails Dec. 4 at 3:44 PM
$RXRX $ABSI did you collect the shares on dips ?
0 · Reply
Momabeat
Momabeat Dec. 4 at 3:01 PM
$ABSI
0 · Reply
Steirve
Steirve Dec. 4 at 1:15 PM
$ABSI news! https://finance.yahoo.com/news/absci-announces-first-participants-dosed-130000353.html
1 · Reply
BioSniper101
BioSniper101 Dec. 4 at 1:09 AM
$ABSI
0 · Reply
BesTrades1
BesTrades1 Dec. 3 at 8:02 PM
$ABSI I bought 1000 shares today at $3.17 holding it long term.
1 · Reply
BioSniper101
BioSniper101 Dec. 3 at 7:06 PM
$ABSI Something tells me that when we look back in a few years, these prices will look ridiculous. Ask Kathie she knows
0 · Reply
mcrotary
mcrotary Dec. 3 at 6:29 PM
1 · Reply
Kennynails
Kennynails Dec. 3 at 4:45 PM
$RXRX $ABSI keep stacking the shares on dips. Holding on tight to both shares not trading it at all 🥰
0 · Reply
Invest2live
Invest2live Dec. 3 at 3:48 PM
$GOSS 246% already; congrats 🎈🌿🎈 Checkout $ABSI and $BBAI
1 · Reply
flam70
flam70 Nov. 30 at 2:56 PM
$ABSI https://www.tipranks.com/news/ratings/strategic-focus-on-abs-201-drives-buy-rating-for-absci-amid-promising-aga-and-endometriosis-market-opportunities-ratings
0 · Reply
Invest2live
Invest2live Nov. 28 at 9:53 PM
$MBIO 27% already; congrats 🎈🌿🎉 Checkout $TTD and $ABSI
0 · Reply